Brask-Lindemann, D <br/><br/>
Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Jun 2013 
 - 1891-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-012-2220-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alendronate--administration & dosage<br/>Bone Density Conservation Agents--administration & dosage<br/>Case-Control Studies<br/>Denmark<br/>Drug Prescriptions--statistics & numerical data<br/>Drug Utilization--statistics & numerical data<br/>Female<br/>Glucocorticoids--adverse effects<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--etiology<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Pulmonary Disease, Chronic Obstructive--complications<br/>Registries<br/>Risk Factors